administers grant
- 3D co-culture system to characterize and target leukemia stem cells
- A novel, short isoform of the +TIP microtubule (MT) binding protein CLIP170 confers taxane resistance by obstructing the MT pore
- A novel, short isoform of the +TIP microtubule (MT) binding protein CLIP170 confers taxane resistance by obstructing the MT pore.
- APOBEC MUTAGENESIS IN BLADDER CANCER: MECHANISMS AND THERAPEUTIC OPPORTUNITIES
- ATHNdataset Hereditary Antithrombin Deficiency (HAD) Pilot Project
- Alliance Initiative to Simplify Clinical Trials in Hematologic Malignancies
- Autologous Dendritic Cell Vaccine for Pancreatic Cancer
- BPARC Agreement- Dr. Ari Melnick
- BRIDGE (Blood cancer Research Initiative Developing Greater Engagement) with Community Patients
- Basic Junior Faculty ASH Scholar Award
- Biomarkers of Taxane Chemotherapy Response/Resistance in Prostate Cancer
- Biomaterials-based Germinal Center Niches for Understanding the B Cell Maturation and B cell receptor signaling
- Biomaterials-based Germinal Center Niches for Understanding the B Cell Maturation and B cell receptor signaling
- Biophysical roles of pre-metatstatic niche evolution on transport of circulating tumor cells
- Characteristics and Outcomes of Patients with Follicular Lymphoma with at Least Two Prior Lines of Systemic Therapy and Treated at Cancer Centers within the LEO Cohort
- Characterizing and Targeting the Follicular Lymphoma Microenvironment
- Core: Targeting Enhancer Dysfunction in Hematological Malignancy- Core B
- Defining the cellular origin and mechanistic basis for therapy resistant B-cell lymphomas
- Design and testing of small molecule compound inhibitors of MALT1.
- Development of Novel Anti-Leukemia Agents Targeting the Menin-MLL Interaction
- Dissecting the Role of APOBEC3 Mutagenic Proteins as Drivers of Genomic-Instability and Chemotherapy-Resistance in Urothelial Carcinoma
- Dissecting the role of CD4+ TFH-like cells as a therapeutic target and biomarker of immunotherapy activity
- Dual CDK4/6 and immune checkpoint inhibitor therapy in indolent non-Hodgkin lymphoma
- ECOG-ACRIN Integrated Leukemia Translational Research Center
- EPIGENOMICS CORE ’s Single Cell sequencing
- Heating cold prostate tumors with PSMA-targeted alpha therapy and pembrolizumab
- Hematology Opportunities for the Next-Generation of Research Scientists (HONORS) Award
- Identifying therapeutic vulnerabilities of aggressive and therapy-resistant MCD/C5-DLBCLs.
- Imaging and targeting glycolytically driven oxidative stress using ascorbate
- Immunogenomic determinants of ethnic disparities in clinical outcomes for urothelial cancer patients
- In vitro Bioreactor System for Platelet Formation
- Karyopharma SRA
- Lymph node-targeted multistage chemoimmunotherapy for lymphoma
- MSK SPORE in Lymphoma
- MSK SPORE in Lymphoma
- Measuring Patient-Reported Outcomes Related to Radiopharmaceuticals for Prostate Cancer
- Molecular and Translational Oncology Research
- Molecular and clinical correlates with prostate-specific membrane antigen (PSMA)-targeted radionuclide therapy
- Novel Strategies for Induction of Aging in Human iPSC-Derived Lineages Towards Improved Models of Late-Onset Diseases
- Potential Genetic and Transcriptomic Mechanisms of Resistance to BTK Inhibition in CLL
- Precision Promise
- Precision medicine deployment of mechanism based Epigenetic – Immune therapy for B-cell lymphoma
- Prostate Cancer Clinical Consortium Clinical Research Site: Targeted Therapies
- Role of BCL10 somatic mutations in lymphomagenesis and response to BCR-targeted therapies
- Role of chromatin remodeling complex BAF in immunity and lymphoma
- Role of chromatin remodeling complex BAF in lymphomagenesis
- Role of defibrotide in modulating platelet reactivity and EC injury induced by TTP and aHUS-type TMA patient plasmas: correlation of in vitro assays with in vivo biomarkers.
- Role of the stromal microenvironment in B-cell lymphoma progression and immune escape
- SIRT3 TARGETED THERAPY FOR B-CELL LYMPHOMAS
- Sanofi Innovation Awards Program
- Service Agreement Boston Gene
- Specific Ablation of AML Stem Cells Through Selective Targeting of HSP70 in the Stem Cell Compartment
- TOX as a putative oncosuppressor in DLBCL
- Targeted Small Molecule Inhibitors for Inv(16) Leukemia
- Targeting Enhancer Dysfunction in Hematological Malignancy- Project 5
- Targeting Epigenetic Circuits in B-Cell Lymphomas
- Targeting Epigenetic Circuits in B-Cell Lymphomas
- Targeting Epigenetic Circuits in B-Cell Lymphomas
- Targeting deregulated epigenetic mechanisms in B-cell lymphomas.
- Temporal Evolution of N-Myc Signaling and Early Targeting of the Neuroendocrine Phenotype in Prostate Cancer
- The Development of Novel 3-D Methods to Study MDS Ex Vivo
- The Lymphoma Epidemiology and Outcomes (LEO) Cohort Study
- The impact of changes in chromatin architecture on cancer phenotypes and tumor progression
- The impact of human spaceflight on clonal hematopoiesis
- The role of BCL10 mutations in lymphomagenesis
- Therapeutic Implications of Altered Epigenetics and DNA Damage Responses in Hematologic Disorders
- Therapeutic Targeting of AR Variant Prostate Cancer with a Novel Antibody Drug Conjugate
- Transcriptional Targeting in Cancer Therapy
- Transferrin Receptor Identifies a Comprehensive pool of Circulating Tumor Cells with unique molecular features from metastatic Prostate Cancer Patients
- Understanding and Targeting Chemotherapy Resistance in Acute Myeloid Leukemia
- Understanding the role of SPEN in marginal zone B cell transformation using three-photon microscopy
- Vitamin D and Follicular Lymphoma